Literature DB >> 25403688

PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.

Souvik Kar1, Amir Samii, Helmut Bertalanffy.   

Abstract

Cerebral cavernous malformations (CCM) are common vascular malformation of the brain and are associated with abnormal angiogenesis. Although the exact etiology and the underlying molecular mechanism are still under investigation, recent advances in the identification of the mutations in three genes and their interactions with different signaling pathways have shed light on our understanding of CCM pathogenesis. The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is known to play a major role in angiogenesis. Studies have shown that the phosphatase and tensin homologue deleted on chromosome ten (PTEN), a tumor suppressor, is an antagonist regulator of the PI3K/Akt pathway and mediates angiogenesis by activating vascular endothelial growth factor (VEGF) expression. Here, we provide an update literature review on the current knowledge of the PTEN/PI3K/Akt/VEGF signaling in angiogenesis, more importantly in CCM pathogenesis. In addition to reviewing the current literatures, this article will also focus on the structural domain of the three CCM proteins and their interacting partners. Understanding the biology of these proteins with respect to their signaling counterpart will help to guide future research towards new therapeutic targets applicable for CCM treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25403688     DOI: 10.1007/s10143-014-0597-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  89 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 2.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

3.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

4.  Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.

Authors:  Yun He; Haifeng Zhang; Luyang Yu; Murat Gunel; Titus J Boggon; Hong Chen; Wang Min
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

5.  A new role for PTEN in regulating transient receptor potential canonical channel 6-mediated Ca2+ entry, endothelial permeability, and angiogenesis.

Authors:  Vidisha Kini; Alejandra Chavez; Dolly Mehta
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

6.  In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.

Authors:  Yuan Zhu; Qun Wu; Moritz Fass; Jin-Fang Xu; Chao You; Oliver Müller; I Erol Sandalcioglu; Jian-Min Zhang; Ulrich Sure
Journal:  Neurosurgery       Date:  2011-09       Impact factor: 4.654

7.  Indications for surgery and prognosis in patients with cerebral cavernous angiomas.

Authors:  H Bertalanffy; G Kühn; R Scheremet; W Seeger
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-08       Impact factor: 1.742

8.  Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation.

Authors:  Weizhi Liu; Kyle M Draheim; Rong Zhang; David A Calderwood; Titus J Boggon
Journal:  Mol Cell       Date:  2013-01-11       Impact factor: 17.970

9.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

10.  The association between cerebral developmental venous anomaly and concomitant cavernous malformation: an observational study using magnetic resonance imaging.

Authors:  Guolu Meng; Chuanfeng Bai; Tengfei Yu; Zhen Wu; Xing Liu; Junting Zhang; Jizong zhao
Journal:  BMC Neurol       Date:  2014-03-15       Impact factor: 2.474

View more
  15 in total

1.  Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.

Authors:  Souvik Kar; Kiran Kumar Bali; Arpita Baisantry; Robert Geffers; Amir Samii; Helmut Bertalanffy
Journal:  J Mol Neurosci       Date:  2017-02-08       Impact factor: 3.444

Review 2.  Vis-à-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis.

Authors:  Concetta Scimone; Luigi Donato; Silvia Marino; Concetta Alafaci; Rosalia D'Angelo; Antonina Sidoti
Journal:  Neurol Sci       Date:  2018-12-06       Impact factor: 3.307

3.  Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice.

Authors:  Ujala Rana; Zhong Liu; Suresh N Kumar; Baofeng Zhao; Wenquan Hu; Michelle Bordas; Stephanie Cossette; Sara Szabo; Jamie Foeckler; Hartmut Weiler; Magdalena Chrzanowska-Wodnicka; Mary L Holtz; Ravindra P Misra; Valerie Salato; Paula E North; Ramani Ramchandran; Qing Robert Miao
Journal:  Dev Biol       Date:  2015-12-31       Impact factor: 3.582

4.  PHACE syndrome is associated with intracranial cavernous malformations.

Authors:  Kimberly A Foster; William J Ares; Zachary J Tempel; Andrew A McCormick; Ashok Panigrahy; Lorelei J Grunwaldt; Stephanie Greene
Journal:  Childs Nerv Syst       Date:  2016-04-28       Impact factor: 1.475

5.  MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.

Authors:  Yan-Ran Wu; Hai-Jun Qi; Dan-Fang Deng; Ying-Ying Luo; Sheng-Lan Yang
Journal:  Tumour Biol       Date:  2016-05-17

Review 6.  Role of Delta-Notch signaling in cerebral cavernous malformations.

Authors:  Souvik Kar; Arpita Baisantry; Arya Nabavi; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2016-01-16       Impact factor: 3.042

7.  PTEN inhibition enhances angiogenesis in an in vitro model of ischemic injury by promoting Akt phosphorylation and subsequent hypoxia inducible factor-1α upregulation.

Authors:  Lixia Xue; Jiankang Huang; Ting Zhang; Xiuzhe Wang; Jianliang Fu; Zhi Geng; Yuwu Zhao; Hao Chen
Journal:  Metab Brain Dis       Date:  2018-06-24       Impact factor: 3.584

8.  Intracerebral Hemorrhage and Ischemic Stroke of Different Etiologies Have Distinct Alternatively Spliced mRNA Profiles in the Blood: a Pilot RNA-seq Study.

Authors:  Cheryl Dykstra-Aiello; Glen C Jickling; Bradley P Ander; Xinhua Zhan; DaZhi Liu; Heather Hull; Miles Orantia; Carolyn Ho; Boryana Stamova
Journal:  Transl Stroke Res       Date:  2015-05-22       Impact factor: 6.829

9.  A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleeds.

Authors:  Petra E Cohn-Hokke; Henne Holstege; Marjan M Weiss; Wiesje M van der Flier; Frederik Barkhof; Erik A Sistermans; Yolande A L Pijnenburg; John C van Swieten; Hanne Meijers-Heijboer; Philip Scheltens
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-06-08       Impact factor: 3.568

10.  miR-25 inhibits sepsis-induced cardiomyocyte apoptosis by targetting PTEN.

Authors:  Yulong Yao; Fangyuan Sun; Ming Lei
Journal:  Biosci Rep       Date:  2018-04-13       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.